Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Acute liver effects, disposition and metabolic fate of [14C]-fenclozic acid following oral administration to normal and bile-cannulated male C57BL/6J mice.

Pickup K, Martin S, Partridge EA, Jones HB, Wills J, Schulz-Utermoehl T, McCarthy A, Rodrigues A, Page C, Ratcliffe K, Sarda S, Wilson ID.

Arch Toxicol. 2017 Jul;91(7):2643-2653. doi: 10.1007/s00204-016-1894-5. Epub 2016 Nov 28.

2.

Implicit and explicit attitudes toward rape are associated with sexual aggression.

Nunes KL, Hermann CA, Ratcliffe K.

J Interpers Violence. 2013 Sep;28(13):2657-75. doi: 10.1177/0886260513487995. Epub 2013 Jun 12.

PMID:
23761302
3.

The hepatic reductase null mouse as a model for exploring hepatic conjugation of xenobiotics: application to the metabolism of diclofenac.

Pickup K, Gavin A, Jones HB, Karlsson E, Page C, Ratcliffe K, Sarda S, Schulz-Utermoehl T, Wilson I.

Xenobiotica. 2012 Feb;42(2):195-205. doi: 10.3109/00498254.2011.607196. Epub 2011 Sep 28.

PMID:
21955249
4.

Vandetanib inhibits both VEGFR-2 and EGFR signalling at clinically relevant drug levels in preclinical models of human cancer.

Brave SR, Odedra R, James NH, Smith NR, Marshall GB, Acheson KL, Baker D, Howard Z, Jackson L, Ratcliffe K, Wainwright A, Lovick SC, Hickinson DM, Wilkinson RW, Barry ST, Speake G, Ryan AJ.

Int J Oncol. 2011 Jul;39(1):271-8. doi: 10.3892/ijo.2011.1022. Epub 2011 Apr 29.

PMID:
21537841
5.

Assessing the activity of cediranib, a VEGFR-2/3 tyrosine kinase inhibitor, against VEGFR-1 and members of the structurally related PDGFR family.

Brave SR, Ratcliffe K, Wilson Z, James NH, Ashton S, Wainwright A, Kendrew J, Dudley P, Broadbent N, Sproat G, Taylor S, Barnes C, Silva JC, Farnsworth CL, Hennequin L, Ogilvie DJ, J├╝rgensmeier JM, Shibuya M, Wedge SR, Barry ST.

Mol Cancer Ther. 2011 May;10(5):861-73. doi: 10.1158/1535-7163.MCT-10-0976. Epub 2011 Mar 25.

6.

Vascular endothelial growth factor receptors VEGFR-2 and VEGFR-3 are localized primarily to the vasculature in human primary solid cancers.

Smith NR, Baker D, James NH, Ratcliffe K, Jenkins M, Ashton SE, Sproat G, Swann R, Gray N, Ryan A, J├╝rgensmeier JM, Womack C.

Clin Cancer Res. 2010 Jul 15;16(14):3548-61. doi: 10.1158/1078-0432.CCR-09-2797. Epub 2010 Jul 6.

7.

An antibody panel for immunohistochemical analysis of the retina in Davidson's-fixed, paraffin-embedded eyes of rats.

McKay JS, Steele SJ, Ahmed G, Johnson E, Ratcliffe K.

Exp Toxicol Pathol. 2009 Mar;61(2):91-100. doi: 10.1016/j.etp.2008.06.005. Epub 2008 Aug 20.

PMID:
18718747
8.

Developing metrics for hospital medical workforce allocation.

Shannon EA, Brand BA, Ratcliffe KM, Tranter BK.

Aust Health Rev. 2007 Aug;31(3):411-21.

PMID:
17669064
9.

Bifunctional gonadotropin-releasing hormone antagonist-progesterone analogs with increased efficacy and duration of action.

Ratcliffe KE, Fraser HM, Sellar R, Rivier J, Millar RP.

Endocrinology. 2006 Jan;147(1):571-9. Epub 2005 Oct 13.

PMID:
16223868
10.

Sck is expressed in endothelial cells and participates in vascular endothelial growth factor-induced signaling.

Ratcliffe KE, Tao Q, Yavuz B, Stoletov KV, Spring SC, Terman BI.

Oncogene. 2002 Sep 12;21(41):6307-16.

11.

Fibroblast growth factor receptor substrate 2 participates in vascular endothelial growth factor-induced signaling.

Stoletov KV, Ratcliffe KE, Terman BI.

FASEB J. 2002 Aug;16(10):1283-5. Epub 2002 Jun 21.

PMID:
12154000
12.

Hospital services in Tasmania.

Duckett S, Geeves P, Kinne L, Ratcliffe K.

Aust Health Rev. 2002;25(1):141-55. No abstract available.

PMID:
11974954
13.

Refugee services. Hosts with the most.

Ratcliffe K.

Health Serv J. 2001 Nov 8;111(5780):22-3.

PMID:
11721539
14.

NCK and PAK participate in the signaling pathway by which vascular endothelial growth factor stimulates the assembly of focal adhesions.

Stoletov KV, Ratcliffe KE, Spring SC, Terman BI.

J Biol Chem. 2001 Jun 22;276(25):22748-55. Epub 2001 Mar 8.

15.

CD14 employs hydrophilic regions to "capture" lipopolysaccharides.

Cunningham MD, Shapiro RA, Seachord C, Ratcliffe K, Cassiano L, Darveau RP.

J Immunol. 2000 Mar 15;164(6):3255-63.

16.

Morphology and functional characteristics of human ovarian microvascular endothelium.

Ratcliffe KE, Anthony FW, Richardson MC, Stones RW.

Hum Reprod. 1999 Jun;14(6):1549-54.

PMID:
10357974
17.

Identification of CD14 residues involved in specific lipopolysaccharide recognition.

Shapiro RA, Cunningham MD, Ratcliffe K, Seachord C, Blake J, Bajorath J, Aruffo A, Darveau RP.

Infect Immun. 1997 Jan;65(1):293-7.

18.

Helicobacter pylori and Porphyromonas gingivalis lipopolysaccharides are poorly transferred to recombinant soluble CD14.

Cunningham MD, Seachord C, Ratcliffe K, Bainbridge B, Aruffo A, Darveau RP.

Infect Immun. 1996 Sep;64(9):3601-8.

19.

Ability of bacteria associated with chronic inflammatory disease to stimulate E-selectin expression and promote neutrophil adhesion.

Darveau RP, Cunningham MD, Bailey T, Seachord C, Ratcliffe K, Bainbridge B, Dietsch M, Page RC, Aruffo A.

Infect Immun. 1995 Apr;63(4):1311-7.

21.

The Leiter scales: a review of validity findings.

Ratcliffe KJ, Ratcliffe MW.

Am Ann Deaf. 1979 Feb;124(1):38-45. No abstract available.

PMID:
443157

Supplemental Content

Loading ...
Support Center